SMALL MOLECULES TARGETING ROR1 INDUCE SPECIFIC KILLING OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) CELLS

被引：0
|
作者：
Moshfegh, A. [1 ]
Khan, S. [1 ]
Vagberg, J. [2 ]
Bystrom, S. [2 ]
Hojat-Farsangi, M. [1 ]
Mansouri, L. [1 ]
Sandin, A. [1 ]
Manesh, A. Danesh [1 ]
Osterborg, A. [3 ]
Mellstedt, H. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Kancera AB, Stockholm, Sweden
[3] Karolinska Univ Hosp, Stockholm, Sweden
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1061
引用
收藏
页码：433 / 433
页数：1
相关论文
共 50 条
  • [21] High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
    Cui, Bing
    Ghia, Emanuela M.
    Chen, Liguang
    Rassenti, Laura Z.
    DeBoever, Christopher
    Widhopf, George F., II
    Yu, Jian
    Neuberg, Donna S.
    Wierda, William G.
    Rai, Kanti R.
    Kay, Neil E.
    Brown, Jennifer R.
    Jones, Jeffrey A.
    Gribben, John G.
    Frazer, Kelly A.
    Kipps, Thomas J.
    BLOOD, 2016, 128 (25) : 2931 - 2940
  • [22] Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells
    Hasan, M. K.
    Yu, J.
    Chen, L.
    Cui, Bing
    Widhopf, G. F., II
    Rassenti, L.
    Shen, Z.
    Briggs, S. P.
    Kipps, T. J.
    LEUKEMIA, 2017, 31 (12) : 2615 - 2622
  • [23] Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia
    Hojjat-Farsangi, Mohammad
    Jeddi-Tehrani, Mahmood
    Daneshmanesh, Amir Hossein
    Mozaffari, Fariba
    Moshfegh, Ali
    Hansson, Lotta
    Razavi, Seyed Mohsen
    Sharifian, Ramazan Ali
    Rabbani, Hodjattallah
    Osterborg, Anders
    Mellstedt, Hakan
    Shokri, Fazel
    PLOS ONE, 2015, 10 (11):
  • [24] Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells
    Md Kamrul Hasan
    Laura Rassenti
    George F. Widhopf
    Jian Yu
    Thomas J. Kipps
    Leukemia, 2019, 33 : 653 - 661
  • [25] ROR1 Negative Chronic Lymphocytic Leukemia (CLL) Have a Distinctive Gene Expression Signature and May Represent an Indolent-Disease Subtype
    Ghia, Emanuela M.
    Rassenti, Laura Z.
    Chen, Liguang
    Cui, Bing
    Deboever, Christopher
    Frazer, Kelly A.
    Kipps, Thomas J.
    BLOOD, 2015, 126 (23)
  • [26] The receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL) using flow cytometry
    Uhrmacher, S.
    Schmidt, C.
    Hallek, M.
    Kreuzer, K. A.
    ONKOLOGIE, 2011, 34 : 137 - 138
  • [27] Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells
    M K Hasan
    J Yu
    L Chen
    Bing Cui
    G F Widhopf II
    L Rassenti
    Z Shen
    S P Briggs
    T J Kipps
    Leukemia, 2017, 31 : 2615 - 2622
  • [28] Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells
    Hasan, Md Kamrul
    Rassenti, Laura
    Widhopf, George F., II
    Yu, Jian
    Kipps, Thomas J.
    LEUKEMIA, 2019, 33 (03) : 653 - 661
  • [29] TREATMENT WITH BCR INHIBITORS INCREASES ROR1 EXPRESSION IN CLL CELLS
    Kotaskova, J.
    Pavlova, S.
    Plevova, K.
    Malcikova, J.
    Stehlikova, O.
    Poppova, L.
    Kockova, H.
    Doubek, M.
    Bryja, V.
    Pospisilova, S.
    HAEMATOLOGICA, 2017, 102 : 414 - 414
  • [30] Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells
    Choudhury, Aniruddha
    Derkow, Katja
    Daneshmanesh, Amir Hossein
    Mikaelsson, Eva
    Kiaii, Shahryar
    Kokhaei, Parviz
    Osterborg, Anders
    Mellstedt, Hakan
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (04) : 327 - 335
12345